Baozou Big News Events

Drilling Tools International Reports Third Quarter 2023 Financial Results

Retrieved on: 
Monday, November 13, 2023
Webcast, Equipment, Baozou Big News Events, Tax, Depreciation, Insurance, Accounting, Earnings call, DTI, Adjustment, News, SHI International Corp, New Çeltek events, Environment, Video game

HOUSTON, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Drilling Tools International Corp., (“DTI” or the “Company”) (Nasdaq: DTI), a leading oilfield services company that manufactures and provides a differentiated, rental-focused offering of tools for use in horizontal and directional drilling, operating from 20 locations across North America, Europe and the Middle East, today reported its financial and operational results for the third quarter ended September 30, 2023.

Key Points: 
  • HOUSTON, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Drilling Tools International Corp., (“DTI” or the “Company”) (Nasdaq: DTI), a leading oilfield services company that manufactures and provides a differentiated, rental-focused offering of tools for use in horizontal and directional drilling, operating from 20 locations across North America, Europe and the Middle East, today reported its financial and operational results for the third quarter ended September 30, 2023.
  • Product Sales Net Revenue in the third quarter totaled $8.8 million, a decrease of 9.6% compared to the third quarter of 2022.
  • Third quarter 2023 Operating Expenses were $(31.0) million, compared to $(28.5) million in the third quarter of 2022.
  • Third quarter 2023 Adjusted EBITDA was $12.7 million, compared to Adjusted EBITDA of $13.0 million in the prior year quarter.

ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
Interest, Research, Intertek, Earnout, Investment, Certification, Administration, SOS, Marketing, United, OSA, News, Growth, Physician, Obstructive sleep apnea, Baozou Big News Events, Travel, Rare-earth element, Pharmaceutical industry, Cryptocurrency

PLEASANTON, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA ), the leading non-CPAP Obstructive Sleep Apnea Therapy, today announced financial results for the third quarter ended September 30, 2023.

Key Points: 
  • PLEASANTON, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA ), the leading non-CPAP Obstructive Sleep Apnea Therapy, today announced financial results for the third quarter ended September 30, 2023.
  • Generated record revenues of $7.1 million in the quarter, representing an increase of 41.5% year-over-year compared to the third quarter of 2022, and $19.8 million for the nine months ended 2023, representing a 45.7% increase compared to 2022.
  • “ProSomnus delivered another record setting quarter further establishing ProSomnus as the leading non-CPAP therapy for Obstructive Sleep Apnea.
  • ProSomnus Chief Executive Officer, Len Liptak, and Chief Financial Officer, Brian Dow, will host a conference call at 1:30 pm PT / 4:30 pm ET to discuss the Company’s quarterly financial results and provide financial guidance for the remainder of 2023.

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
Marketing, Hyperfine structure, FDA, News, Research, Baozou Big News Events, Video game, Reinsurance, Cryptocurrency

Gross margin for the third quarter of 2023 was $1.12 million, resulting in a 48% gross margin, compared to $0.69 million in the third quarter of 2022.

Key Points: 
  • Gross margin for the third quarter of 2023 was $1.12 million, resulting in a 48% gross margin, compared to $0.69 million in the third quarter of 2022.
  • Research and development expenses for the third quarter of 2023 were $5.74 million, compared to $7.34 million in the third quarter of 2022.
  • Sales, marketing, general, and administrative expenses for the third quarter of 2023 were $7.14 million, compared to $6.63 million in the third quarter of 2022.
  • ET on Thursday, November 9, 2023, to discuss its third quarter 2023 financial results and provide a business update.

Semtech Announces Third Quarter of Fiscal Year 2024 Results

Retrieved on: 
Wednesday, December 6, 2023
Semiconductor, Data Management, IOT (Internet of Things), Technology, Networks, Internet, EBITDA, Acquisition, Security (finance), Annual report, Bank statement, Investment, Risk, Depreciation, Insurance, Public expenditure, GAAP, Sierra Wireless, Table, R, Growth, Loss, Baozou Big News Events, Bank, Audit, Semtech

The Company expects the variability of the above charges to have a potentially significant impact on its GAAP financial results.

Key Points: 
  • The Company expects the variability of the above charges to have a potentially significant impact on its GAAP financial results.
  • Semtech will be hosting a conference call today to discuss its third fiscal quarter 2024 results at 2:00 p.m. Pacific time.
  • To provide additional insight into the Company's fourth quarter outlook, this release also includes a presentation of forward-looking non-GAAP financial measures.
  • For fiscal year 2024, the Company's projected non-GAAP normalized tax rate is 12% and will be applied to each quarter of fiscal year 2024.

KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference

Retrieved on: 
Wednesday, November 29, 2023
Managed Care, Pharmaceutical, Health, Medical Devices, Interest, KORU, Quality of life, Patient, Baozou Big News Events, KRMD, Conference, Pharmaceutical industry, Piper

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023.

Key Points: 
  • KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023.
  • KORU Medical's management is scheduled to present at Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023, at 1:30 pm ET.
  • Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com .

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

Retrieved on: 
Tuesday, November 28, 2023
Medical Devices, Health, Pharmaceutical, Health Technology, Medical Supplies, KORU, Quality of life, Patient, KRMD, Baozou Big News Events

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced it will host an investor day at the Mahwah, NJ headquarters on Tuesday, December 5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time.

Key Points: 
  • KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced it will host an investor day at the Mahwah, NJ headquarters on Tuesday, December 5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time.
  • The event will include presentations by members of management and an expert immunologist.
  • The presentations will cover KORU Medical’s key markets, growth strategy, product portfolio, and operational and financial performance.
  • For those who cannot attend in-person, a live and archived webcast of the presentations will be available on the News/Events page of the Investors section of KORU Medical System's website at www.korumedical.com .

Inogen to Present at Upcoming Investor Conferences in November 2023

Retrieved on: 
Thursday, November 9, 2023
Managed Care, Health Technology, Health, Medical Devices, Disclosure, Baozou Big News Events, Regulation, Conference, News, Regulation Fair Disclosure, Pharmaceutical industry

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:

Key Points: 
  • Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
    Stifel 2023 Healthcare Conference on Wednesday, November 15 at 10:20 a.m. Eastern Time
    Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29 at 10:30 a.m. Eastern Time
    A live webcast and archived recording of each presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.
  • Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/ , as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
  • For more information, visit http://investor.inogen.com/ .

Life360 to Participate in Upcoming Investor Conference

Retrieved on: 
Tuesday, November 21, 2023
ASX, Life360, Summon (company), SAN, Baozou Big News Events, Mobile phone, Broadcasting

SAN FRANCISCO, Nov. 21, 2023 /PRNewswire/ -- San Francisco area-based Life360, Inc. (Life360 or the Company) (ASX: 360) today announced that the Company would participate in the following investor conference:

Key Points: 
  • SAN FRANCISCO, Nov. 21, 2023 /PRNewswire/ -- San Francisco area-based Life360, Inc. (Life360 or the Company) (ASX: 360) today announced that the Company would participate in the following investor conference:
    A live webcast of the event and the archived webcast will be accessible from the "News & Events" section of the Company's Investor Relations website here.

Nuvve Provides Third Quarter 2023 Financial Update

Retrieved on: 
Thursday, November 9, 2023
Sale, EPA, Astrea, Baozou Big News Events, Engineering, SAN, Insurance, Research, Marketing, Advertising, AC, VIE, Partnership, Forecasting, Total, Growth, EV, Bluebird, Satellite navigation device, Renewable energy, Life insurance, Nuvve Kavali

SAN DIEGO, Nov. 9, 2023 /PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today provided a third quarter 2023 update. 

Key Points: 
  • SAN DIEGO, Nov. 9, 2023 /PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today provided a third quarter 2023 update.
  • Products and services margin decreased to 9.0% for the three months ended September 30, 2023, compared to 43.3% in the same prior year period.
  • In each of the three months ended September 30, 2023 and 2022, we recorded no material income tax expenses.
  • The Company will hold a conference call to review its financial results for the third quarter of 2023, along with other Company developments, at 5:00 PM Eastern Time (2:00 PM PT) today, Thursday, November 9, 2023.

Recludix Pharma to Present at Two Investor Conferences in November

Retrieved on: 
Thursday, November 9, 2023
Baozou Big News Events, Pharming, Inflammation, News, Cancer, Conference, NY, SAN, Pharmaceutical industry

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, today announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in November.

Key Points: 
  • SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, today announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in November.
  • Stifel 2023 Healthcare Conference in New York, NY
    Presentation on Tuesday, November 14, 2023 from 9:10 – 9:40 a.m.
  • ET
    Piper Sandler 35th Annual Healthcare Conference in New York, NY
    Presentation on Wednesday, November 29, 2023 from 3:10 – 3:30 p.m.
  • ET
    To access available live and archived webcasts, visit the News & Events page of the company’s website at https://recludixpharma.com/news-events .